Deepa Seetharam | Neuroscience | Women Researcher Award

Published on by Young Scientists Awards

Women Researcher Award

Deepa Seetharam
University of Miami
Deepa Seetharam
Affiliation University of Miami
Country United States
Scopus ID 57205548812
Documents 11
Citations 247
h-index 8
Subject Area Neuroscience
Event International Young Scientists Award
ORCID 0000-0002-4886-5025

Deepa Seetharam is a neuroscience researcher affiliated with the University of Miami, United States, whose academic work has contributed to contemporary investigations in brain science, neural mechanisms, and related biomedical research areas. Her scholarly profile demonstrates active engagement in neuroscience research, reflected through indexed publications, citation records, and international academic visibility.[1] Her research contributions have gained recognition through academic indexing platforms including Scopus and Google Scholar, where her publications and citation metrics illustrate sustained scholarly activity.[2]

Abstract

This academic article presents a concise overview of the scholarly profile and research activities of Deepa Seetharam in the field of neuroscience. Her work is associated with interdisciplinary approaches that contribute to the understanding of neural systems, neurological mechanisms, and biomedical sciences. Through publications indexed in recognized scientific databases, her research demonstrates engagement with contemporary scientific questions relevant to neuroscience and health sciences.[1] The article further evaluates her publication profile, research influence, citation performance, and suitability for academic recognition under the International Young Scientists Award program.[4]

Keywords

  • Neuroscience
  • Brain Research
  • Biomedical Science
  • Scientific Publications
  • Women Researcher Award
  • Research Impact
  • Academic Recognition
  • Scopus Author Profile

Introduction

Neuroscience is an interdisciplinary scientific domain focused on understanding the structure, function, and mechanisms of the nervous system. Modern neuroscience research integrates biology, medicine, computational analysis, and cognitive science to investigate neurological processes and diseases.[3] Researchers working in this field contribute to scientific advancements that may influence diagnostics, therapeutic strategies, and broader biomedical understanding.

Research Profile

The research profile of Deepa Seetharam reflects active participation in neuroscience-oriented scientific investigations. According to indexed academic databases, her publication record includes eleven scientific documents with a cumulative citation count exceeding two hundred citations.[1] The recorded h-index of 8 further indicates that multiple publications have received measurable scholarly attention within the scientific community.[2]

Research Contributions

Research contributions in neuroscience frequently involve collaborative scientific efforts addressing neurological pathways, brain activity, and disease-related mechanisms. Deepa Seetharam’s scholarly engagement demonstrates participation in research areas relevant to neuroscience and biomedical sciences.[1] Scientific publications indexed through Scopus and other academic platforms provide evidence of her contribution to peer-reviewed research dissemination.

Publications

The publication portfolio associated with Deepa Seetharam demonstrates scholarly participation in neuroscience research communication. Academic publications indexed through Scopus and Google Scholar contribute to the dissemination of scientific findings and provide measurable indicators of academic productivity.[1]

Research Impact

Research impact is commonly assessed through publication visibility, citation metrics, collaborative influence, and academic dissemination. The citation record associated with Deepa Seetharam’s scholarly profile suggests that her publications have contributed to scientific dialogue within neuroscience-related research areas.[1]

Award Suitability

The International Young Scientists Award recognizes researchers demonstrating scientific productivity, academic engagement, and measurable research influence. Based on available academic indicators, Deepa Seetharam’s scholarly profile aligns with several evaluation factors commonly associated with research recognition programs.[4]

Conclusion

Deepa Seetharam represents an active contributor within the field of neuroscience through her publication activities, citation record, and institutional research engagement. Her academic profile reflects participation in scientific inquiry relevant to neuroscience and biomedical research. The measurable research indicators associated with her work demonstrate scholarly visibility and continuing academic relevance.[1] [4]

References

  1. Elsevier. (n.d.). Scopus author details: Deepa Seetharam, Author ID 57205548812. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57205548812
  2. Google Scholar. (n.d.). Deepa Seetharam citation profile.
    https://scholar.google.com/citations?user=8LH_thgAAAAJ&hl=en&oi=ao
  3. Purves, D. et al. (2018). Neuroscience and modern brain research methodologies.
    DOI: https://doi.org/10.1038/nrn3241
  4. International Young Scientists Award. (n.d.). Award evaluation and academic recognition criteria.
    https://youngscientistawards.com/

Akash Vikal | Pharmacology | Young Scientist Award

Published on by Young Scientists Awards

Young Scientist Award

Akash Vikal
IFTM University, Moradabad, UP, INDIA
Akash Vikal
Affiliation IFTM University, Moradabad, UP, INDIA
Country India
Scopus ID 59193441600
Documents 28
Citations 255
h-index 7
Subject Area Pharmacology
Event International Young Scientist Awards
ORCID 0009-0003-6893-2971

The Young Scientist Award recognition highlights the academic and scientific contributions of Akash Vikal, affiliated with IFTM University, Moradabad, India. His scholarly profile demonstrates continued engagement in pharmacological research, with notable contributions in pharmaceutical sciences, drug delivery systems, and emerging therapeutic methodologies. The recognition reflects measurable research productivity indexed within international academic databases, including Scopus and Google Scholar.[1]

Abstract

Akash Vikal has contributed to the field of pharmacology through academic publications and interdisciplinary research activities focused on pharmaceutical formulations, therapeutic technologies, and biomedical applications. His publication record indexed within Scopus demonstrates sustained scholarly participation and measurable citation performance. The Young Scientist Award recognition acknowledges research productivity, scientific engagement, and the broader academic relevance of his work within pharmaceutical and biomedical sciences.[2]

Keywords

Pharmacology, Pharmaceutical Sciences, Drug Delivery Systems, Biomedical Research, Therapeutics, Nanomedicine, Academic Research, Scopus Publications, Citation Impact, Young Scientist Award

Introduction

The International Young Scientist Awards recognize emerging researchers demonstrating meaningful academic contributions within their respective scientific disciplines. Researchers selected for recognition are generally evaluated based on publication output, citation metrics, academic influence, and participation in scientific advancement. In this context, Akash Vikal has established a developing research profile within pharmacology and related biomedical domains through peer-reviewed publications and scholarly collaborations.[3]

Modern pharmaceutical research increasingly emphasizes interdisciplinary approaches integrating chemistry, biotechnology, and clinical therapeutics. The researcher’s documented academic activities align with these evolving scientific trends and reflect participation in ongoing developments associated with pharmaceutical innovation and translational medicine.[4]

Research Profile

Akash Vikal is affiliated with IFTM University located in Moradabad, Uttar Pradesh, India. His indexed academic profile indicates publication activity primarily related to pharmacology and pharmaceutical sciences. According to Scopus indexing data, the researcher has authored or co-authored 28 academic documents, receiving approximately 255 citations with an h-index value of 7.[1]

  • Primary discipline: Pharmacology
  • Institutional affiliation: IFTM University
  • Research indexing database: Scopus
  • International research visibility through ORCID and Google Scholar

Research Contributions

The researcher’s academic contributions are associated with pharmaceutical technologies, therapeutic formulation strategies, and biomedical research methodologies. Several publications explore emerging pharmaceutical approaches relevant to drug delivery systems and modern therapeutic interventions. Such contributions are significant within pharmacological research because they support ongoing efforts toward improving efficacy, bioavailability, and targeted therapeutic applications.[5]

Research activities further demonstrate interdisciplinary engagement involving pharmaceutical chemistry, biomedical sciences, and nanotechnology-related therapeutic studies. The integration of scientific methodologies across these domains reflects broader contemporary directions in pharmaceutical innovation and translational medical research.[6]

  • Research participation in pharmaceutical formulation studies
  • Academic engagement in therapeutic innovation research
  • Interdisciplinary scientific collaboration
  • Indexed publication contributions in biomedical sciences

Publications

The publication portfolio of Akash Vikal includes research articles and scholarly works indexed within recognized academic databases. Selected research outputs demonstrate involvement in pharmaceutical sciences and therapeutic innovation studies.[2]

  1. Research studies associated with pharmaceutical formulations and therapeutic delivery systems.
  2. Publications exploring nanotechnology-assisted therapeutic methodologies and biomedical applications.
  3. Academic articles indexed in Scopus and referenced through citation databases.

Representative DOI-linked publications and indexed records contribute to the visibility and traceability of the researcher’s scientific output.[7]

Research Impact

Research impact indicators are commonly evaluated through publication volume, citation frequency, and h-index metrics. Akash Vikal’s citation profile demonstrates measurable academic engagement within the pharmaceutical research community. Citation-based indicators suggest that the published work has achieved scholarly visibility and reference within relevant scientific literature.[1]

Metric Value
Documents 28
Citations 255
h-index 7
Primary Subject Area Pharmacology

Award Suitability

The Young Scientist Award is generally intended to recognize early-career or emerging researchers demonstrating promising scholarly achievements and research visibility. Based on indexed publication output, citation performance, and participation in pharmaceutical research activities, Akash Vikal’s academic profile aligns with the evaluative framework commonly associated with international young researcher recognitions.[3]

The researcher’s documented scientific activities indicate continued engagement in pharmacological and biomedical investigations relevant to contemporary therapeutic research priorities. Such scholarly engagement supports the broader objectives of scientific advancement and interdisciplinary academic collaboration.[6]

Conclusion

Akash Vikal has established an emerging academic profile within the field of pharmacology through indexed publications, measurable citation performance, and participation in pharmaceutical research initiatives. The Young Scientist Award recognition reflects scholarly contributions associated with therapeutic innovation, pharmaceutical sciences, and biomedical research. Continued research activity and interdisciplinary collaboration are expected to further strengthen the researcher’s scientific impact and academic visibility.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Akash Vikal, Author ID 59193441600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59193441600
  2. Google Scholar. (n.d.). Academic citation profile of Akash Vikal.
    https://scholar.google.com/citations?user=DmTcek4AAAAJ&hl=en&oi=sra
  3. International Young Scientist Awards. (n.d.). Award evaluation and recognition criteria.
    https://youngscientistawards.com/
  4. Allen, T. M., & Cullis, P. R. (2013). Liposomal drug delivery systems: From concept to clinical applications.DOI: https://doi.org/10.1016/S0140-6736(13)61809-7
  5. Patra, J. K., et al. (2018). Nano based drug delivery systems: Recent developments and future prospects.DOI: https://doi.org/10.1016/j.jconrel.2018.10.015
  6. Peer, D., et al. (2007). Nanocarriers as an emerging platform for cancer therapy.DOI: https://doi.org/10.1038/nnano.2007.387
  7. Torchilin, V. P. (2014). Multifunctional nanocarriers.DOI: https://doi.org/10.1038/nrd.2014.73

İsmail Ibrahim | Neuroscience | Editorial Board Member

Published on by Young Scientists Awards

Mr. Ismail Ibrahim | Neuroscience | Editorial Board Member

Fenerbahçe University | Turkey

Mr. Ismail Ibrahim is an emerging multidisciplinary researcher whose work spans neurobiology, physiotherapy, public health, clinical neuroscience, oncology, infectious diseases, and evidence-based rehabilitation sciences. His research portfolio includes numerous peer-reviewed publications, systematic reviews, meta-analyses, case reports, and multinational cross-sectional studies addressing critical clinical and epidemiological problems. He has contributed to major studies on post-COVID-19 health challenges, public responses to infectious disease outbreaks, vaccine awareness, and antimicrobial resistance, alongside impactful research on glioblastoma progression, neurodegenerative disorders, immuno-oncology, and advanced diagnostic techniques. His scientific output also extends to innovative investigations on stem-cell-based therapies, neuromodulation interventions such as tDCS and TMS, robotic-assisted rehabilitation technologies, cardiovascular robotic surgery, musculoskeletal rehabilitation, sports performance, and pediatric and adult neurological conditions. He has produced extensive work analyzing cancer outcomes using large clinical databases, explored radiological and thermographic diagnostic tools, and conducted comprehensive reviews on endocrine disorders, metabolic diseases, and neuroimmunological interactions. His submissions further highlight contributions to AI integration in healthcare, high-fidelity surgical simulation, endocrinology, neurorehabilitation, physiotherapy optimization, and global public health threats including Nipah virus and monkeypox. Through his broad research involvement across diverse medical and scientific disciplines, he demonstrates a strong commitment to advancing clinical evidence, improving patient outcomes, and informing healthcare innovation through rigorous, multidisciplinary inquiry.

Featured Publications

Shaheen, N., Shaheen, A., Ramadan, A., Hefnawy, M. T., Ramadan, A., et al. (2023). Appraising systematic reviews: A comprehensive guide to ensuring validity and reliability. Frontiers in Research Metrics and Analytics, 8, 1268045.

Swed, S., Alibrahim, H., Bohsas, H., Jawish, N., Rais, M. A., Nasif, M. N., Hafez, W., et al. (2023). A multinational cross-sectional study on the awareness and concerns of healthcare providers toward monkeypox and the promotion of the monkeypox vaccination. Frontiers in Public Health, 11, 1153136.

Swed, S., Bohsas, H., Alibrahim, H., Rakab, A., Hafez, W., Sawaf, B., Amir, R. M., et al. (2023). Monkeypox post-COVID-19: Knowledge, worrying, and vaccine adoption in the Arabic general population. Vaccines, 11(4), 759

Hamna Rafiq | Neuropharmacology | Best Researcher Award

Published on by Young Scientists Awards

Dr. Hamna Rafiq | Neuropharmacology | Best Researcher Award

Research Officer, Pakistan Council of Scientific and Industrial Research

Dr. Hamna Rafiq is a Research Officer at the Pharmaceutical Research Centre, Pakistan Council of Scientific & Industrial Research (PCSIR), Karachi. She holds a PhD in Biochemistry from the University of Karachi, focusing on neuroendocrine and behavioral abnormalities in oxidative stress models. Her expertise lies in neuropharmacology, pharmaceutical analysis, and cannabinoid research. She has contributed significantly to the development of cannabis-derived products, pharmaceutical raw material testing, and method validation per ICH and USP guidelines. Dr. Rafiq has extensive experience in HPLC, GC-MS, and ISO 17025 accreditation processes. Previously, she worked at Aga Khan University, researching natural antidepressants like chamomile and saffron. She has authored multiple high-impact research papers on neuropharmacology, cannabinoids, and neurodegenerative diseases. An active trainer, she has conducted hands-on workshops on advanced analytical techniques. Her research continues to explore therapeutic interventions for neuropathy, dementia, and neuroinflammation using pharmacological and computational approaches.

Profile

Scholar

🎓 Education 

Dr. Hamna Rafiq completed her PhD in Biochemistry from the University of Karachi (2015-2022). Her doctoral research explored the long-term effects of quercetin on behavioral and neuroendocrine abnormalities caused by oxidative stress in rats. She earned her MSc in Biochemistry (2012-2014) from the same institution, investigating the effects of a high-fat diet on stress response in a chronic mild stress rat model of depression. Throughout her academic journey, she gained expertise in pharmacological interventions, biochemical analysis, and neurobehavioral assessments. She has received extensive training in molecular techniques, protein purification, and tissue culture, enhancing her research capabilities. Additionally, she has attended specialized courses in analytical techniques such as HPLC and GC-MS. Dr. Rafiq’s educational background provides a strong foundation for her research in neuropharmacology, pharmaceutical development, and cannabinoid-based therapeutics, making significant contributions to biomedical sciences and drug discovery.

💼 Experience 

Dr. Hamna Rafiq has been a Research Officer at PCSIR, Karachi, since January 2022, where she specializes in cannabinoid extraction, pharmaceutical raw material testing, and method validation. She developed an animal model for chemotherapy-induced neuropathic pain to evaluate cannabinoid effects on dementia and psychological symptoms. She is proficient in HPLC, GC-MS, and ISO 17025 accreditation. From 2019 to 2021, she worked as a Research Associate at Aga Khan University, conducting clinical trials on chamomile and saffron for depression treatment. Her responsibilities included patient follow-ups, biochemical analyses, and documentation. Previously, she interned at PCSIR and ICCBS, gaining hands-on experience in quality control, analytical techniques, and neuronal cell culture. She also serves as a trainer for analytical instruments and has organized multiple workshops. Dr. Rafiq’s expertise spans neuropharmacology, drug discovery, and biomedical research, contributing to advancements in therapeutic interventions for neurological and psychological disorders.

🏆 Awards & Honors 

Dr. Hamna Rafiq has received multiple accolades for her contributions to neuropharmacology and pharmaceutical research. She has been recognized for her work in cannabis-derived therapeutics and neurodegenerative disease studies. In 2024, she received advanced training certifications in Lab Management Systems (LMS) and Internal Audits from the Pakistan National Accreditation Council. She has also been honored for organizing hands-on workshops on HPLC and GC-MS, training professionals and students in analytical methodologies. Her research publications in high-impact journals have earned significant recognition in the scientific community. She has contributed to ISO 17025 accreditation efforts for cannabinoid analysis, further strengthening laboratory quality assurance. Additionally, her pioneering research on saffron and chamomile as natural antidepressants has been widely acknowledged. With multiple peer-reviewed publications and active participation in international research collaborations, Dr. Rafiq continues to gain recognition as an emerging leader in neuropharmacology and biomedical sciences.

🔬 Research Focus 

Dr. Hamna Rafiq’s research focuses on neuropharmacology, cannabinoid therapeutics, and pharmaceutical analysis. She investigates the neuroprotective and anti-inflammatory properties of cannabis-derived compounds, particularly in treating neuropathy, dementia, and neurodegenerative disorders. Her work includes developing extraction methods for cannabinoids, optimizing analytical techniques for CBD and THC quantification, and ensuring compliance with pharmaceutical standards. She has also explored the effects of natural antidepressants like chamomile and saffron in clinical settings. Dr. Rafiq specializes in animal models for chemotherapy-induced pain and oxidative stress-related neurological disorders. Her expertise extends to method validation and impurity profiling in pharmaceutical raw materials, ensuring drug safety and efficacy. Through her computational studies, she identifies novel cannabinoid-based treatments targeting inflammatory pathways. Her interdisciplinary research integrates pharmacology, biochemistry, and analytical chemistry, contributing to drug discovery and therapeutic advancements in neuroscience and mental health.

Conclusion

Dr. Rafiq’s extensive research experience, publication record, and dedication to training make her a strong candidate for the Best Researcher Award. Addressing the identified areas for improvement could further bolster her candidacy and contribute to her professional growth.

Publication

M Farhan, H Rafi, H Rafiq (2018) – Behavioral evidence of neuropsychopharmacological effect of imipramine in animal model of unpredictable stress induced depression – 34 citations

 

H Rafi, H Rafiq, R Khan, F Ahmad, J Anis, M Farhan (2019) – Neuroethological study of ALCL3 and chronic forced swim stress induced memory and cognitive deficits in albino rats – 33 citations

 

H Rafiq, M Farhan, H Rafi, S Rehman, M Arshad, S Shakeel (2022) – Inhibition of drug induced Parkinsonism by chronic supplementation of quercetin in haloperidol-treated wistars – 32 citations

 

H Rafi, H Rafiq, M Farhan (2021) – Inhibition of NMDA receptors by agmatine is followed by GABA/glutamate balance in benzodiazepine withdrawal syndrome – 32 citations

 

H Rafi, H Rafiq, M Farhan (2024) – Pharmacological profile of agmatine: An in-depth overview – 30 citations

 

H Rafi, H Rafiq, M Farhan (2021) – Antagonization of monoamine reuptake transporters by agmatine improves anxiolytic and locomotive behaviors commensurate with fluoxetine and methylphenidate – 30 citations

 

M Farhan, H Rafi, H Rafiq (2015) – Dapoxetine treatment leads to attenuation of chronic unpredictable stress induced behavioral deficits in rats model of depression – 30 citations

 

H Rafi, F Ahmad, J Anis, R Khan, H Rafiq, M Farhan (2020) – Comparative effectiveness of agmatine and choline treatment in rats with cognitive impairment induced by AlCl3 and forced swim stress – 29 citations

 

M Farhan, H Rafiq, H Rafi, S Rehman, M Arshad (2022) – Quercetin impact against psychological disturbances induced by fat rich diet – 27 citations

 

M Farhan, H Rafiq, H Rafi, R Ali, S Jahan (2019) – Neuroprotective role of quercetin against neurotoxicity induced by lead acetate in male rats – 27 citations

 

H Rafi, H Rafiq, I Hanif, R Rizwan, M Farhan (2018) – Chronic agmatine treatment modulates behavioral deficits induced by chronic unpredictable stress in wistar rats – 27 citations

 

H Rafi, H Rafiq, M Farhan (2023) – Agmatine alleviates brain oxidative stress induced by sodium azide – 26 citations

 

M Farhan, H Rafi, H Rafiq, F Siddiqui, R Khan, J Anis (2019) – Study of mental illness in rat model of sodium azide induced oxidative stress – 24 citations

 

S Ahmad, SB Ahmed, A Khan, M Wasim, S Tabassum, S Haider, F Ahmed, … (2024) – Natural remedies for Alzheimer’s disease: A systematic review of randomized controlled trials – Metabolic brain disease 38 (1), 17-44